The gut-brain axis : Correlation of choroid plexus volume and permeability with inflammatory biomarkers in Crohn's disease
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved..
BACKGROUND: The dysregulation of the gut-brain axis in chronic inflammatory bowel diseases can cause neuro-psychological disturbances, but the underlying mechanisms are still not fully understood. The choroid plexus (CP) maintains brain homeostasis and nourishment through the secretion and clearance of cerebrospinal fluid. Recent research has demonstrated the existence of a CP vascular barrier in mice which is modulated during intestinal inflammation. This study investigates possible correlations between CP modifications and inflammatory activity in patients with Crohn's disease (CD).
METHODS: In this prospective study, 17 patients with CD underwent concomitant abdominal and brain 3 T MRI. The volume and permeability of CP were compared with levels of C-reactive protein (CRP), fecal calprotectin (FC), sMARIA and SES-CD scores.
RESULTS: The CP volume was negatively correlated with CRP levels (R = -0.643, p-value = 0.024) and FC (R = -0.571, p-value = 0.050). DCE metrics normalized by CP volume were positively correlated with CRP (K-trans: R = 0.587, p-value = 0.045; Vp: R = 0.706, p-value = 0.010; T1: R = 0.699, p-value = 0.011), and FC (Vp: R = 0.606, p-value = 0.037).
CONCLUSIONS: Inflammatory activity in patients with CD is associated with changes in CP volume and permeability, thus supporting the hypothesis that intestinal inflammation could affect the brain through the modulation of CP vascular barrier also in humans.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:192 |
---|---|
Enthalten in: |
Neurobiology of disease - 192(2024) vom: 01. März, Seite 106416 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bonifacio, Cristiana [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 01.03.2024 Date Revised 01.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.nbd.2024.106416 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367625520 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367625520 | ||
003 | DE-627 | ||
005 | 20240301232407.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240126s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.nbd.2024.106416 |2 doi | |
028 | 5 | 2 | |a pubmed24n1313.xml |
035 | |a (DE-627)NLM367625520 | ||
035 | |a (NLM)38272141 | ||
035 | |a (PII)S0969-9961(24)00015-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bonifacio, Cristiana |e verfasserin |4 aut | |
245 | 1 | 4 | |a The gut-brain axis |b Correlation of choroid plexus volume and permeability with inflammatory biomarkers in Crohn's disease |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.03.2024 | ||
500 | |a Date Revised 01.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. | ||
520 | |a BACKGROUND: The dysregulation of the gut-brain axis in chronic inflammatory bowel diseases can cause neuro-psychological disturbances, but the underlying mechanisms are still not fully understood. The choroid plexus (CP) maintains brain homeostasis and nourishment through the secretion and clearance of cerebrospinal fluid. Recent research has demonstrated the existence of a CP vascular barrier in mice which is modulated during intestinal inflammation. This study investigates possible correlations between CP modifications and inflammatory activity in patients with Crohn's disease (CD) | ||
520 | |a METHODS: In this prospective study, 17 patients with CD underwent concomitant abdominal and brain 3 T MRI. The volume and permeability of CP were compared with levels of C-reactive protein (CRP), fecal calprotectin (FC), sMARIA and SES-CD scores | ||
520 | |a RESULTS: The CP volume was negatively correlated with CRP levels (R = -0.643, p-value = 0.024) and FC (R = -0.571, p-value = 0.050). DCE metrics normalized by CP volume were positively correlated with CRP (K-trans: R = 0.587, p-value = 0.045; Vp: R = 0.706, p-value = 0.010; T1: R = 0.699, p-value = 0.011), and FC (Vp: R = 0.606, p-value = 0.037) | ||
520 | |a CONCLUSIONS: Inflammatory activity in patients with CD is associated with changes in CP volume and permeability, thus supporting the hypothesis that intestinal inflammation could affect the brain through the modulation of CP vascular barrier also in humans | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Choroid plexus | |
650 | 4 | |a Crohn's disease | |
650 | 4 | |a DCE MRI | |
650 | 4 | |a Gut-brain axis | |
650 | 4 | |a Inflammation | |
650 | 4 | |a Magnetic resonance imaging | |
650 | 4 | |a Permeability | |
650 | 4 | |a Plexus vascular barrier | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a C-Reactive Protein |2 NLM | |
650 | 7 | |a 9007-41-4 |2 NLM | |
650 | 7 | |a Leukocyte L1 Antigen Complex |2 NLM | |
700 | 1 | |a Savini, Giovanni |e verfasserin |4 aut | |
700 | 1 | |a Reca, Christian |e verfasserin |4 aut | |
700 | 1 | |a Garoli, Federico |e verfasserin |4 aut | |
700 | 1 | |a Levi, Riccardo |e verfasserin |4 aut | |
700 | 1 | |a Vatteroni, Giulia |e verfasserin |4 aut | |
700 | 1 | |a Balzarini, Luca |e verfasserin |4 aut | |
700 | 1 | |a Allocca, Mariangela |e verfasserin |4 aut | |
700 | 1 | |a Furfaro, Federica |e verfasserin |4 aut | |
700 | 1 | |a Dal Buono, Arianna |e verfasserin |4 aut | |
700 | 1 | |a Armuzzi, Alessandro |e verfasserin |4 aut | |
700 | 1 | |a Danese, Silvio |e verfasserin |4 aut | |
700 | 1 | |a Matteoli, Michela |e verfasserin |4 aut | |
700 | 1 | |a Rescigno, Maria |e verfasserin |4 aut | |
700 | 1 | |a Fiorino, Gionata |e verfasserin |4 aut | |
700 | 1 | |a Politi, Letterio S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neurobiology of disease |d 1997 |g 192(2024) vom: 01. März, Seite 106416 |w (DE-627)NLM089461223 |x 1095-953X |7 nnns |
773 | 1 | 8 | |g volume:192 |g year:2024 |g day:01 |g month:03 |g pages:106416 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nbd.2024.106416 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 192 |j 2024 |b 01 |c 03 |h 106416 |